Ketone body transport in the human neonate and infant

Insights

Infant ketone body transport is active and significant, comparable to adults after fasting. Ketone bodies can supply up to 25% of a neonate

Area of Science:

  • Biochemistry
  • Neonatal Physiology
  • Metabolic Research

Background:

  • Ketone bodies are crucial energy substrates, particularly during fasting.
  • Understanding infant ketone metabolism is vital for assessing neonatal energy needs and development.

Purpose of the Study:

  • To quantify ketone body transport and metabolism in human infants.
  • To compare infant ketone metabolism with adult patterns.
  • To determine the contribution of ketone bodies to neonatal energy requirements.

Main Methods:

  • Continuous intravenous infusion of a D-(-)-3-hydroxy[4,4,4-2H3]butyrate tracer.
  • Measurement of ketone body inflow-outflow transport (flux) in various infant groups (newborns, older infants, diabetic, hyperinsulinemic).
  • Analysis of relationships between ketone turnover, free fatty acid, and ketone body concentrations.

Main Results:

  • Infant ketone body transport rates are comparable to adult values after short fasting periods.
  • Ketone body turnover is proportional to free fatty acid and ketone concentrations, and inversely related to clearance.
  • Ketone bodies may provide up to 25% of a neonate's basal energy needs.

Conclusions:

  • Human infants exhibit active ketogenesis and significant ketone body fuel transport.
  • Regulatory systems for ketone body metabolism are established early in postnatal life.
  • Ketone bodies play a quantitatively important role in infant energy metabolism.

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.4K
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.0K
Carbon Dioxide Transport in the Blood01:19

Carbon Dioxide Transport in the Blood

Carbon dioxide (CO2) transport in the blood is critical to human physiology. On average, our body cells produce around 200 mL of CO2 per minute, precisely the quantity expelled by the lungs. This process involves the transportation of CO2 from the tissue cells to the lungs in three primary forms.
Forms of CO2 Transport
1. Dissolved in plasma: A small percentage (7-10%) of CO2 is transported and dissolved directly in the plasma.
2. Carbaminohemoglobin: Just over 20% of CO2 is chemically bound to...
6.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410